title: Treatment options for ophthalmoplegic migraine.
authors.forename: Lig
authors.initials: L
authors.lastname: Granado
authors.forename: G
authors.initials: G
authors.lastname: Guillen
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D009886:Ophthalmoplegia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015348:Vision, Binocular
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A